THE USE OF SEMAGLUTIDE (ANALOG OF GLP-1) IN THE TREATMENT OF OBESITY
Obesity is a complex pathology that affects virtually all stages of life, regardless of socioeconomic groups. GLP-1 analogues are potentially promising drugs for weight loss in obese or overweight adults and at least one comorbidity. An integrative review of the use of the GLP-1 analogue semaglutide in the treatment of obesity and weight loss therapy was reviewed, analyzing the STEP (Semaglutide Treatment Effect in People with Obesity) study.
THE USE OF SEMAGLUTIDE (ANALOG OF GLP-1) IN THE TREATMENT OF OBESITY
-
DOI: 10.22533/at.ed.1592432201088
-
Palavras-chave: Obesity. Pharmacological treatment. LPG-1
-
Keywords: Obesity. Pharmacological treatment. LPG-1
-
Abstract:
Obesity is a complex pathology that affects virtually all stages of life, regardless of socioeconomic groups. GLP-1 analogues are potentially promising drugs for weight loss in obese or overweight adults and at least one comorbidity. An integrative review of the use of the GLP-1 analogue semaglutide in the treatment of obesity and weight loss therapy was reviewed, analyzing the STEP (Semaglutide Treatment Effect in People with Obesity) study.
-
Número de páginas: 9
- Paulo Octávio Nadaf Pouso Tôrres Cruz
- Christiane Yule de Barros Figueiredo
- Thayanne Rysia Gomes Bezerra
- Andrela Colombo Martins
- Luciana Marques da Silva
- Giovana Elisa Rosa Galiassi
